You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 新冠檢測板塊走低 九安醫療(002432.SZ)跌逾8%
格隆匯2月11日丨新冠檢測板塊走低,九安醫療(002432.SZ)跌逾8%,華康醫療跌逾7%,之江生物跌逾5%,易瑞生物、安旭生物、蘭衞醫學、熱景生物等紛紛走低。據九安醫療最新披露,在2月10日接受機構調研的電話會議中,針對公司在美國的經營情況,九安醫療表示,目前是供需緊張情況有所緩解,公司目前的交貨排期有所縮短,根據目前的排產計劃,即將可以按計劃滿足政府和商業客户需求,美國公佈的新增病例較前期有所降低,也存在因用試劑盒自測沒有主動上報而沒有被統計的情況。公司正在履行的合同及訂單尚未受到影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account